Andrew Yurochko, PhD
Professor and Carroll Feist Endowed Chair of Viral Oncology and Department Vice-Chair of Microbiology and Immunology
Areas of Specialty
HCMV/Immune Cell Function
Dr. Andrew D. Yurochko received a BS in both Biochemistry and Biology from Virginia Tech and then a PhD in the Immunology Section of the Department of Biological Sciences at Virginia Tech. He received postdoctoral training at the Lineberger Comprehensive Cancer Center at the University of North Carolina in Dr. Steven Haskill’s laboratory on the molecular understanding of human monocyte inflammatory biology, and then further training in Dr. Eng-Shang Huang’s laboratory on the pathobiology of human cytomegalovirus (HCMV) infection.
Dr. Yurochko is currently Professor and Vice-Chair of Microbiology and Immunology and the Carroll Feist Endowed Chair in Viral Oncology. He is also the Assistant Director and Director of Research in the Center of Excellence in Arthritis and Rheumatology and Interim Director of Research in the Feist-Weiller Cancer Center.
Research: Dr. Yurochko’s career has focused largely on understanding how functional changes in immune cells (monocytes, macrophages and hematopoietic stem cells) are involved in human disease. Dr. Yurochko’s current research focuses on the investigation of how HCMV infects and utilizes bone marrow progenitor cells, and monocytes and macrophages to promote life-long viral persistence and how infection of these critical in vivo targets contributes to the serious acute and chronic viral-mediated diseases observed in infected people. HCMV is the leading infectious cause of birth defects in the United States and a leading cause of morbidity and mortality in solid organ and bone marrow transplant recipients. HCMV infection is also associated with the development and severity of the cardiovascular diseases, atherosclerosis and restenosis.